Prognostic value of integrative genomic approaches for IDH-mutant gliomas.
作者信息
Gallo Marco
机构信息
Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, Texas, USA.
Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.
出版信息
Neuro Oncol. 2023 Nov 2;25(11):2042-2043. doi: 10.1093/neuonc/noad151.
Abstract
摘要
相似文献
1
Prognostic value of integrative genomic approaches for IDH-mutant gliomas.整合基因组学方法对异柠檬酸脱氢酶（IDH）突变型胶质瘤的预后价值
Neuro Oncol. 2023 Nov 2;25(11):2042-2043. doi: 10.1093/neuonc/noad151.
2
Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.线粒体丙酮酸载体在异柠檬酸脱氢酶突变型脑胶质瘤中的预后作用。
J Neurosurg. 2019 Jan 1;130(1):56-66. doi: 10.3171/2017.9.JNS172036.
3
Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting.在临床环境中通过磁共振波谱技术无创评估脑胶质瘤异柠檬酸脱氢酶基因突变状态。
J Neurosurg. 2018 Feb;128(2):391-398. doi: 10.3171/2016.10.JNS161793. Epub 2017 Mar 3.
4
Identification of a Good-Prognosis IDH-Mutant-Like Population of Patients with Diffuse Gliomas.弥漫性胶质瘤中具有良好预后的异柠檬酸脱氢酶（IDH）突变样患者群体的鉴定
Curr Mol Med. 2018 Mar 9;17(7):518-526. doi: 10.2174/1566524018666180212151429.
5
Isocitrate Dehydrogenase Mutations Are Associated with Different Expression and DNA Methylation Patterns of OLIG2 in Adult Gliomas.异柠檬酸脱氢酶突变与成人胶质瘤中 OLIG2 的不同表达和 DNA 甲基化模式相关。
J Neuropathol Exp Neurol. 2022 Aug 16;81(9):707-716. doi: 10.1093/jnen/nlac059.
6
Perspectives on IDH Mutation in Diffuse Gliomas.弥漫性胶质瘤中异柠檬酸脱氢酶（IDH）突变的观点
Trends Cancer. 2018 Sep;4(9):605-607. doi: 10.1016/j.trecan.2018.06.006. Epub 2018 Jul 13.
7
PCR-Based Simple Subgrouping Is Validated for Classification of Gliomas and Defines Negative Prognostic Copy Number Aberrations in IDH Mutant Gliomas.基于PCR的简单亚组分类法在胶质瘤分类中得到验证，并确定了异柠檬酸脱氢酶（IDH）突变型胶质瘤中的不良预后拷贝数畸变。
PLoS One. 2015 Nov 11;10(11):e0142750. doi: 10.1371/journal.pone.0142750. eCollection 2015.
8
Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.在 IDH 突变型和 IDH 野生型弥漫性胶质瘤中，使用端粒酶启动子突变来标记具有相互临床行为的特定分子亚群。
J Neurosurg. 2018 Apr;128(4):1102-1114. doi: 10.3171/2016.11.JNS16973. Epub 2017 Jun 16.
9
Intraoperative assessment of isocitrate dehydrogenase mutation status in human gliomas using desorption electrospray ionization-mass spectrometry.应用解吸电喷雾电离-质谱技术对人脑胶质瘤异柠檬酸脱氢酶突变状态的术中评估。
J Neurosurg. 2019 Jan 4;132(1):180-187. doi: 10.3171/2018.8.JNS181207. Print 2020 Jan 1.
10
Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications.异柠檬酸脱氢酶突变在弥漫性神经胶质瘤中的作用：临床和病因学意义。
J Clin Pathol. 2011 Oct;64(10):835-44. doi: 10.1136/jclinpath-2011-200227. Epub 2011 Jul 12.
引用本文的文献
1
Hypoxia-driven M2-polarized macrophages facilitate the epithelial-mesenchymal transition of glioblastoma via extracellular vesicles.缺氧驱动的 M2 极化巨噬细胞通过细胞外囊泡促进胶质母细胞瘤的上皮间质转化。
Theranostics. 2024 Oct 7;14(16):6392-6408. doi: 10.7150/thno.95766. eCollection 2024.
本文引用的文献
1
Integrated molecular analysis reveals hypermethylation and overexpression of HOX genes to be poor prognosticators in isocitrate dehydrogenase mutant glioma.整合分子分析显示，HOX 基因的高甲基化和过表达是异柠檬酸脱氢酶突变型胶质瘤的不良预后标志物。
Neuro Oncol. 2023 Nov 2;25(11):2028-2041. doi: 10.1093/neuonc/noad126.
2
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类：概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
3
Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling.通过基于基因表达谱的预后特征识别异柠檬酸脱氢酶（IDH）突变型胶质瘤。
Aging (Albany NY). 2018 Aug 15;10(8):1977-1988. doi: 10.18632/aging.101521.
4
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.对12种癌症类型的多平台分析揭示了原发组织内部和之间的分子分类。
Cell. 2014 Aug 14;158(4):929-944. doi: 10.1016/j.cell.2014.06.049. Epub 2014 Aug 7.
5
HOX genes and their role in the development of human cancers.HOX基因及其在人类癌症发展中的作用。
J Mol Med (Berl). 2014 Aug;92(8):811-23. doi: 10.1007/s00109-014-1181-y. Epub 2014 Jul 5.
6
A tumorigenic MLL-homeobox network in human glioblastoma stem cells.人胶质母细胞瘤干细胞中的致瘤性 MLL-同源盒网络。
Cancer Res. 2013 Jan 1;73(1):417-27. doi: 10.1158/0008-5472.CAN-12-1881. Epub 2012 Oct 29.
7
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.鉴定出一种 CpG 岛甲基化表型，它定义了神经胶质瘤的一个独特亚群。
Cancer Cell. 2010 May 18;17(5):510-22. doi: 10.1016/j.ccr.2010.03.017. Epub 2010 Apr 15.
8
IDH1 and IDH2 mutations in gliomas.胶质瘤中的异柠檬酸脱氢酶1（IDH1）和异柠檬酸脱氢酶2（IDH2）突变
N Engl J Med. 2009 Feb 19;360(8):765-73. doi: 10.1056/NEJMoa0808710.
9
An integrated genomic analysis of human glioblastoma multiforme.多形性胶质母细胞瘤的综合基因组分析
Science. 2008 Sep 26;321(5897):1807-12. doi: 10.1126/science.1164382. Epub 2008 Sep 4.
10
Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma.干细胞相关的“自我更新”特征以及高表皮生长因子受体表达与胶质母细胞瘤同步放化疗耐药相关。
J Clin Oncol. 2008 Jun 20;26(18):3015-24. doi: 10.1200/JCO.2007.15.7164.
Zotero 插件